9 results
-
List item
Referral: Agopton
Lansoprazole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/09/2006, EC decision date: 13/12/2006, Last updated: 20/12/2006oral suspension Oral use LANSOX 15 mg Capsule Oral use LANSOX 30 mg Capsule Oral use LANGAST … 30 mg Capsule Oral use LANSOX 15 mg Oro-dispersible tablet … Oro-dispersible tablet Oral use LANSOX 30 mg Oro-dispersible tablet … -
List item
Orphan designation: hydrocortisone for: Treatment of adrenal insufficiency
Date of designation: 22/05/2006, Expired, Last updated: 25/11/2021 -
List item
Orphan designation: hydrocortisone for: Treatment of congenital adrenal hyperplasia
Date of designation: 27/07/2005, Positive, Last updated: 14/06/2021 -
List item
Orphan designation: dexamethasone for: Treatment of multiple myeloma
Date of designation: 09/06/2010, Withdrawn, Last updated: 12/02/2018kezelése Italian Desametasone (compressa da 40 mg) Trattamento del … -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 March 2017
European Medicines Agency, London, UK, from 20/03/2017 to 23/03/2017, Last updated: 20/03/2017 -
List item
Outcomes of imposed non-interventional post-authorisation safety studies
Last updated: 27/06/2022 -
List item
Guidance documents
Last updated: 19/07/2022 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
CHMP: meeting archive 2016-2018
Last updated: 26/02/2020